Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Unlabeled Competitor Antibody to Reduce Nonlinear Signal Spillover in Mass Cytometry.

Sekhri P, Kim MY, Behbehani GK.

Cytometry A. 2019 Aug;95(8):898-909. doi: 10.1002/cyto.a.23793. Epub 2019 May 23.

PMID:
31120628
2.

Mass Cytometric Cell Cycle Analysis.

Behbehani GK.

Methods Mol Biol. 2019;1989:193-215. doi: 10.1007/978-1-4939-9454-0_13.

PMID:
31077107
3.

Effect of storage time and temperature on cell cycle analysis by mass cytometry.

Devine RD, Sekhri P, Behbehani GK.

Cytometry A. 2018 Nov;93(11):1141-1149. doi: 10.1002/cyto.a.23630. Epub 2018 Oct 31.

PMID:
30378741
4.

CD56 Expression Marks Human Group 2 Innate Lymphoid Cell Divergence from a Shared NK Cell and Group 3 Innate Lymphoid Cell Developmental Pathway.

Chen L, Youssef Y, Robinson C, Ernst GF, Carson MY, Young KA, Scoville SD, Zhang X, Harris R, Sekhri P, Mansour AG, Chan WK, Nalin AP, Mao HC, Hughes T, Mace EM, Pan Y, Rustagi N, Chatterjee SS, Gunaratne PH, Behbehani GK, Mundy-Bosse BL, Caligiuri MA, Freud AG.

Immunity. 2018 Sep 18;49(3):464-476.e4. doi: 10.1016/j.immuni.2018.08.010. Epub 2018 Sep 4.

PMID:
30193847
5.

Genetic Inactivation of CD33 in Hematopoietic Stem Cells to Enable CAR T Cell Immunotherapy for Acute Myeloid Leukemia.

Kim MY, Yu KR, Kenderian SS, Ruella M, Chen S, Shin TH, Aljanahi AA, Schreeder D, Klichinsky M, Shestova O, Kozlowski MS, Cummins KD, Shan X, Shestov M, Bagg A, Morrissette JJD, Sekhri P, Lazzarotto CR, Calvo KR, Kuhns DB, Donahue RE, Behbehani GK, Tsai SQ, Dunbar CE, Gill S.

Cell. 2018 May 31;173(6):1439-1453.e19. doi: 10.1016/j.cell.2018.05.013. Epub 2018 May 31.

6.

Applications of Mass Cytometry in Clinical Medicine: The Promise and Perils of Clinical CyTOF.

Behbehani GK.

Clin Lab Med. 2017 Dec;37(4):945-964. doi: 10.1016/j.cll.2017.07.010. Review.

PMID:
29128078
7.

Cell Cycle Analysis by Mass Cytometry.

Behbehani GK.

Methods Mol Biol. 2018;1686:105-124. doi: 10.1007/978-1-4939-7371-2_8.

PMID:
29030816
8.

Prognostic and biological significance of the proangiogenic factor EGFL7 in acute myeloid leukemia.

Papaioannou D, Shen C, Nicolet D, McNeil B, Bill M, Karunasiri M, Burke MH, Ozer HG, Yilmaz SA, Zitzer N, Behbehani GK, Oakes CC, Steiner DJ, Marcucci G, Powell BL, Kolitz JE, Carter TH, Wang ES, Mrózek K, Croce CM, Caligiuri MA, Bloomfield CD, Garzon R, Dorrance AM.

Proc Natl Acad Sci U S A. 2017 Jun 6;114(23):E4641-E4647. doi: 10.1073/pnas.1703142114. Epub 2017 May 22.

9.

Mass cytometry analysis reveals hyperactive NF Kappa B signaling in myelofibrosis and secondary acute myeloid leukemia.

Fisher DAC, Malkova O, Engle EK, Miner CA, Fulbright MC, Behbehani GK, Collins TB, Bandyopadhyay S, Zhou A, Nolan GP, Oh ST.

Leukemia. 2017 Sep;31(9):1962-1974. doi: 10.1038/leu.2016.377. Epub 2016 Dec 23.

10.

Reversibility of Defective Hematopoiesis Caused by Telomere Shortening in Telomerase Knockout Mice.

Raval A, Behbehani GK, Nguyen le XT, Thomas D, Kusler B, Garbuzov A, Ramunas J, Holbrook C, Park CY, Blau H, Nolan GP, Artandi SE, Mitchell BS.

PLoS One. 2015 Jul 2;10(7):e0131722. doi: 10.1371/journal.pone.0131722. eCollection 2015.

11.

Mass Cytometric Functional Profiling of Acute Myeloid Leukemia Defines Cell-Cycle and Immunophenotypic Properties That Correlate with Known Responses to Therapy.

Behbehani GK, Samusik N, Bjornson ZB, Fantl WJ, Medeiros BC, Nolan GP.

Cancer Discov. 2015 Sep;5(9):988-1003. doi: 10.1158/2159-8290.CD-15-0298. Epub 2015 Jun 19.

12.

Palladium-based mass tag cell barcoding with a doublet-filtering scheme and single-cell deconvolution algorithm.

Zunder ER, Finck R, Behbehani GK, Amir el-AD, Krishnaswamy S, Gonzalez VD, Lorang CG, Bjornson Z, Spitzer MH, Bodenmiller B, Fantl WJ, Pe'er D, Nolan GP.

Nat Protoc. 2015 Feb;10(2):316-33. doi: 10.1038/nprot.2015.020. Epub 2015 Jan 22.

13.

Transient partial permeabilization with saponin enables cellular barcoding prior to surface marker staining.

Behbehani GK, Thom C, Zunder ER, Finck R, Gaudilliere B, Fragiadakis GK, Fantl WJ, Nolan GP.

Cytometry A. 2014 Dec;85(12):1011-9. doi: 10.1002/cyto.a.22573. Epub 2014 Oct 1.

14.

Single-cell mass cytometry adapted to measurements of the cell cycle.

Behbehani GK, Bendall SC, Clutter MR, Fantl WJ, Nolan GP.

Cytometry A. 2012 Jul;81(7):552-66. doi: 10.1002/cyto.a.22075. Epub 2012 Jun 12.

15.

BLM helicase facilitates RNA polymerase I-mediated ribosomal RNA transcription.

Grierson PM, Lillard K, Behbehani GK, Combs KA, Bhattacharyya S, Acharya S, Groden J.

Hum Mol Genet. 2012 Mar 1;21(5):1172-83. doi: 10.1093/hmg/ddr545. Epub 2011 Nov 21.

16.

The APC tumor suppressor inhibits DNA replication by directly binding to DNA via its carboxyl terminus.

Qian J, Sarnaik AA, Bonney TM, Keirsey J, Combs KA, Steigerwald K, Acharya S, Behbehani GK, Barton MC, Lowy AM, Groden J.

Gastroenterology. 2008 Jul;135(1):152-62. doi: 10.1053/j.gastro.2008.03.074. Epub 2008 Apr 4.

17.

The APC tumor suppressor promotes transcription-independent apoptosis in vitro.

Steigerwald K, Behbehani GK, Combs KA, Barton MC, Groden J.

Mol Cancer Res. 2005 Feb;3(2):78-89.

18.

Association and regulation of the BLM helicase by the telomere proteins TRF1 and TRF2.

Lillard-Wetherell K, Machwe A, Langland GT, Combs KA, Behbehani GK, Schonberg SA, German J, Turchi JJ, Orren DK, Groden J.

Hum Mol Genet. 2004 Sep 1;13(17):1919-32. Epub 2004 Jun 30.

PMID:
15229185

Supplemental Content

Loading ...
Support Center